Baldwin, D.S., Buis, C. and Mayers, A.G., 2002. Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder. Expert Review of Neurotherapeutics, 2 (5), pp. 717-724.
This is the latest version of this eprint.
Full text available as:
Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive–compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder.
|Subjects:||Technology > Medicine and Health|
|Group:||School of Design, Engineering & Computing|
|Deposited By:||Dr Andrew Mayers|
|Deposited On:||31 Jan 2011 16:03|
|Last Modified:||07 Mar 2013 15:41|
Available Versions of this Item
- Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder. (deposited 31 Jan 2011 10:22)
- Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder. (deposited 31 Jan 2011 16:03) [Currently Displayed]
Document DownloadsMore statistics for this item...
|Repository Staff Only -|
|BU Staff Only -|
|Help Guide -||Editing Your Items in BURO|